Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

March 12, 2025

Scientific Statement Reviews Current Antithrombotic Options in PAD

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

August 26, 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

News Conference News ISC 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

February 08, 2024

Statin Use, at Any Dose, Not Linked to Excess Dementia Risk in FH

News Daily News

Statin Use, at Any Dose, Not Linked to Excess Dementia Risk in FH

Yael L. Maxwell

April 22, 2022

Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy

News Daily News

Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy

March 07, 2022

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

News Daily News

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

June 22, 2021

Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan

News Daily News

Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan

January 07, 2021

More Teamwork, Coordination Could Boost CV Studies in COVID-19

News Daily News

More Teamwork, Coordination Could Boost CV Studies in COVID-19

October 28, 2020

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

News Daily News

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers

Yael L. Maxwell

September 20, 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

August 31, 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

News Conference News ACC 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Yael L. Maxwell

March 22, 2019

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

March 05, 2018

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

January 02, 2018

Blood in Urine Carries Consequences for Patients on Antithrombotics

News Daily News

Blood in Urine Carries Consequences for Patients on Antithrombotics

Yael L. Maxwell

October 09, 2017

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

May 23, 2017

‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum

News Daily News

‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum

April 27, 2017

Rising Subdural Hematoma Rates Appear to Be Linked to Greater Use of Antithrombotics

News Daily News

Rising Subdural Hematoma Rates Appear to Be Linked to Greater Use of Antithrombotics

March 03, 2017

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Presentation

Impact of Proton Pump Inhibitors (PPIs) on GI Bleeding Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Post-MI Patients Taking Antithrombotics

Presenter: Schjerning Olsen

October 28, 2015

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

June 20, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.